EuroPainClinics® Study V (Prospective Observational Study)

Europainclinics z.ú.500 enrolled

Overview

In this prospective observational trial the effect of the Endoscopic discectomy microinvasive therapy should be examined in (approximately 500) adult patients with low back pain.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

500

Conditions

Back Pain Intervertebral Disc Herniation

Interventions

Endoscopic disectomyPROCEDURE

Endoscopic discectomy is an established method for treatment of lumbar disc herniation. Edoscopic discectomy provides a safe and minimal access corridor for lumbar discectomy. The technique also allows early postoperative mobilization and faster return to work.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * lumbar disc prolapse with unilateral radiculopathy, on clinical evaluation, positive straight leg raise or femoral stretch test, and identification of a single nerve root lesion on MRI Exclusion Criteria: * The exlusion criteria: bilateral root symptoms, double root involvement, cauda equina syndrome and negative MRI Picture for disc herniation, unsigned infomed consent

Locations (1)

Europainclinics algesiology ambulance

Bardejov, Slovakia

Outcomes

Primary Outcomes

1.Pain as assessed by the Visual analogue scale All acquired information will be noted in to the special anonymous protocol

All acquired information will be noted in to the special anonymous protocol

Time frame: 3 years

Secondary Outcomes

2.Pain localization as assessed by note of radiating dermatome as neurologic examination

All acquired information will be noted in to the special anonymous protocol

Time frame: 3 years

3.Pain progress as assessed by global pain scale

All acquired information will be noted in to the special anonymous protocol

Time frame: 3 years

4. Changes in analgesics drugs consumption as assessed by equianalgesic dose ratios for opioids

All acquired information will be noted in to the special anonymous protoco

Time frame: 3 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.